ADVERTISEMENT
ADVERTISEMENT
A vial labeled “RSV vaccine” on a reflective surface next to a syringe and stethoscope.
After Decades of Delays, RSV Vaccines Show Promise in Early Data 
Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.
After Decades of Delays, RSV Vaccines Show Promise in Early Data 
After Decades of Delays, RSV Vaccines Show Promise in Early Data 

Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.

Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.

RSV
Micrograph of influenza A virus and RSV
Flu/RSV Coinfection Produces Hybrid Virus that Evades Immune Defenses
Catherine Offord | Oct 25, 2022 | 2 min read
When fused to RSV, influenza A virus is better able to escape antibodies that usually neutralize it, an in vitro study finds.
three children outside with winter gear wearing surgical masks
The Pandemic Crushed the Flu—What Happens When It Returns?
Diana Kwon | Jul 7, 2021 | 8 min read
Cases of influenza and other respiratory viruses sank dramatically during the pandemic, with potential implications for both people and pathogens.  
b cell crispr immunity rsv respiratory syncitial virus
CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses
Katarina Zimmer | May 17, 2019 | 5 min read
In line with previous research, a new study in mice demonstrates that B cells can be engineered to ward off infections, this time against respiratory syncytial virus (RSV).
ADVERTISEMENT